Big Week Ahead For Stocks… And Emergent’s Mpox Approval 8/30/24

CNBC's "Fast Money"

August trading is in the books, and after a rough start to the month, stocks managed to rebound. But with a big week on deck, can the bounce back continue? Plus Biotech company Emergent Bio getting FDA approval for its smallpox vaccine to treat mpox. What it could mean for Emergent’s future and the space as a whole. 

 

Fast Money Disclaimer


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

2024-08-30 43 min

Available Results

Generated results are saved to the knowledge database for reuse and search.

No generated results are available for this episode yet.

Extract Knowledge

Pick what you want extracted first. Model, scope, and chapter options appear after a template is selected.

Generated results for public episodes are saved to the knowledge database so they can be reused and searched later.

Transcript

No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in

Chapters

No chapters available.